Earnings Call · Q4 FY2024·2025-03-27

Q4 24EPS +29.27%·Rev n/aQ3 24EPS -7.69%·Rev n/aQ2 24EPS +17.39%·Rev n/aQ1 24EPS 0.00%·Rev n/a⚠ consensus missing

ADC Therapeutics SA ADCT

−3.8%1d on move date−3.5% vs SPY3d−10.8%5d−15.8%

Research tier

Behavioral profile computed for this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more ADCT calls or request research access.

More ADCT calls Browse calls Request research access